アルツハイマー病「未病期」バイオマーカーの同定と発症・進行機構の解明

• Project/Area Number: 25K02445
• Research Category: Grant-in-Aid for Scientific Research (B)
• Allocation Type: Multi-year Fund
• Section: 一般
• Review Section: Basic Section 48030:Pharmacology-related
• Research Institution: University of Toyama
• Principal Investigator: 久米 利明 富山大学, 学術研究部薬学・和漢系, 教授 (10303843)
• Project Period (FY): 2025-04-01 – 2028-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥18,200,000 (Direct Cost: ¥14,000,000、Indirect Cost: ¥4,200,000); Fiscal Year 2027: ¥8,710,000 (Direct Cost: ¥6,700,000、Indirect Cost: ¥2,010,000); Fiscal Year 2026: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000); Fiscal Year 2025: ¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)